Pflügers Archiv

, Volume 431, Issue 1, pp 117–124 | Cite as

Coexistence of two classes of glibenclamide-inhibitable ATP-regulated K+ channels in avian skeletal muscle

  • Michel Fosset
  • Bruno Allard
  • Michel Lazdunski
Original Article Neurophysiology, Muscle and Sensory Organs


Avian skeletal muscle expresses two types of ATP-sensitive K+ channels which have a unitary conductance of 15 pS. These K+ channels can be distinguished pharmacologically by their high or low sensitivity to the antidiabetic sulphonylurea blocker glibenclamide. Both channels are activated by the K+ channel opener cromakalim. Chick skeletal muscle expresses high-affinity binding sites for [3H]glibenclamide (Kd=0.6 nM) which presumably correspond to the ATP-sensitive K+ channels with the greatest sensitivity to glibenclamide. The density of these high-affinity binding sites varies during muscle development. The maximum density (500 fmol/mg protein) appears at 16 days in ovo, i.e. at a period when myoblasts have di¤erentiated into myotubes and when innervation of myotubes has started. After this maximum, the level of [3H]glibenclamide-binding sites decreases to a plateau value of 100 fmol/mg protein at 2–5 days postnatal. When muscle cells are put in cultures, the high-affinity binding sites disappear rapidly. Neither glibenclamide nor cromakalim have any effect on normal physiological chick muscle contraction. They have no effect on contracture and/or 86Rb+ efflux produced by metabolic poisoning.

Key words

Muscle KATP channels Glibenclamide Avian muscle contraction Binding studies Muscle poisoning 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aguilar-Bryan L, Nelson DA, Vu QA, Humphrey MB, Boyd AE III (1990) Photoaffinity labeling and partial purification of the β cell sulfonlylurea receptor using a novel, biologically active glyburide analog. J Biol Chem 265:8218–8224Google Scholar
  2. 2.
    Allard B, Lazdunski M (1992) Nucleotide diphosphates activate the ATP-sensitive potassium channel in mouse skeletal muscle. Pflügers Arch 422:185–192Google Scholar
  3. 3.
    Allard B, Lazdunski M (1993) Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells. Eur J Pharmacol 236:419–426Google Scholar
  4. 4.
    Ashcroft SJH, Ashcroft FM (1990) Properties and functions of ATP-sensitive K+channels. Cell Signal 2:197–214Google Scholar
  5. 5.
    Ashford MLJ, Bond CT, Blair TA, Adelman JP (1994) Cloning and functional expression of a rat heart KATP channel. Nature 370:456–459Google Scholar
  6. 6.
    Bernardi H, Fosset M, Lazdunski M (1988) Characterization, purification and affinity labelling of the brain [3H]glibenclamide binding protein, a putative neuronal ATP-regulated K+ channel. Proc Natl Acad Sci USA 85:9816–9820Google Scholar
  7. 7.
    Bernardi H, Fosset M, Lazdunski M (1992) ATP/ADP binding sites are present in the sulfonylurea binding protein associated with brain ATP-sensitive K+ channels. Biochemistry 31:6328–6332Google Scholar
  8. 8.
    Bernardi H, De Weille JR, Epelbaum J, Mourre C, Amoroso S, Slama A, Fosset M, Lazdunski M (1993) ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release. Proc Natl Acad Sci USA 90:1340–1344Google Scholar
  9. 9.
    Bois H, Romey G, Lazdunski M (1991) Indolizinsulphones. A class of blockers with dual but discriminative effects on L-type Ca2+ channel activity and excitation-concentration coupling in skeletal muscle. Pflügers Arch 419:651–656Google Scholar
  10. 10.
    Castle NA, Haylett DG (1987) Effect of channel blockers on potassium efflux from metabolically exhausted frog skeletal muscle. J Physiol (Lond) 383:31–43Google Scholar
  11. 11.
    Davies NW, Standen NB, Stanfield PR (1991) ATP-dependent potassium channels of muscle cells: their properties, regulation, and possible functions. J Bioenerg Biomembr 23:509–535Google Scholar
  12. 12.
    Dunne MJ, Petersen OH (1991) Potassium selective ion channels in insulin-secreting cells: physiology, pharmacology and their role in stimulus-secretion coupling. Biochim Biophys Acta 1071:67–82Google Scholar
  13. 13.
    Edwards G, Weston AH (1993) The pharmacology of ATP sensitive potassium channels. Annu Rev Pharmacol Toxicol 33:597–637Google Scholar
  14. 14.
    Findlay I (1993) Sulphonlyurea drugs no longer inhibit ATP sensitive K+ channels during metabolic stress in cardiac muscle. J Pharmacol Exp Ther 266:456–467Google Scholar
  15. 15.
    Fosset M, De Weille JR, Green RD, Schmid-Antomarchi H, Lazdunski M (1988) Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptor that are linked to ATP-dependent K+ channels. J Biol Chem 263:7933–7936Google Scholar
  16. 16.
    Gopalakrishnan M, Janis RA, Triggle DJ (1993) ATP-sensitive K+ channels: pharmacological properties, regulation and therapeutic potentials. Drug Dev Res 28:95–127Google Scholar
  17. 17.
    Guillemare E, Lazdunski M, Honoré E (1995) Glibenclamide opens ATP-sensitive potassium channels in Xenopus oocyte follicular cells during metabolic stress. Mol Pharmacol 47:588–594Google Scholar
  18. 18.
    Honoré E, Lazdunski M (1993) Single-channel properties and regulation of pinacidil/glibenclamide-sensitive K+ channels in follicular cells from Xenopus oocyte. Pflügers Arch 424:113–121Google Scholar
  19. 19.
    Khan RR, Hales CN, Ozanne SE, Adogu AA, Ashford MLJ (1993) Dissociation of KATP channel and sulfonylurea receptor in the rat clonal insulin-secreting cell line, CRI-D11. Proc R Soc Lond [Biol] 253:225–231Google Scholar
  20. 20.
    Kramer W, Müller G, Girbig F, Gutjahr U, Kowalewski S, Hartz D, Summ HD (1994) Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor. II Photoaffinity labelling of a 65 kDa protein by [3H]glimepiride. Biochim Biophys Acta 1191:278–290Google Scholar
  21. 21.
    Nelson DA, Aguilar-Bryan L, Bryan J (1992) Specificity of photolabeling of β-cell membrane proteins with an 125-I-labeled glyburide analog. J Biol Chem 267:14928–14933Google Scholar
  22. 22.
    Niki I, Welsh M, Berggren PO, Hubbard P, Ashcroft SAJ (1991) Characterization of the solubilized glibenclamide receptor in a hamster pancreatic β-cell line, HIT T15. Biochem J 277:619–624Google Scholar
  23. 23.
    Quast U (1992) Potassium channel openers: pharmacological and clinical aspects. Fundam Clin Pharmacol 6:279–293Google Scholar
  24. 24.
    Quast U, Cook NS (1989) Moving together: K+ channel openers and ATP-sensitive K+ channels. Trends Pharmacol Sci 10:431–435Google Scholar
  25. 25.
    Quasthoff S, Franke C, Hatt H, Richter-Turtur M (1990) Two different types of potassium channels in human skeletal muscle activated by potassium channel openers. Neurosci Lett 119:191–194Google Scholar
  26. 26.
    Sauviat MP, Ecault E, Faivre JF, Findlay I (1991) Activation of ATP-sensitive K channels by a K channel opener (SR 44866) and the effect upon electrical and mechanical activity of frog skeletal muscle. Pflügers Arch 418:261–265Google Scholar
  27. 27.
    Schmid A, Kazazoglou T, Renaud JF, Lazdunski M (1984) Comparative changes of levels of nitrendipine Ca2+ channels, of tetrodotoxin-sensitive Na+ channel and of ouabain-sensitive (Na+, K+)ATPase following denervation of rat and chick skeletal muscle. FEBS Lett 172:114–118Google Scholar
  28. 28.
    Schmid A, Renaud JF, Fosset M, Méaux JP, Lazdunski M (1984) The nitrendipine-sensitive Ca2+ channel in chick muscle cells and its appearance during myogenesis in vitro and in vivo. J Biol Chem 259:11366–11367Google Scholar
  29. 29.
    Schmid-Antomarchi H, De Weille JR, Fosset M, Lazdunski M (1987) The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin secreting cells. J Biol Chem 262:15840–15844Google Scholar
  30. 30.
    Schwanstecher M, Löser S, Chudziak F, Panten U (1994) Identification of a 38-kDa high affinity sulfonylurea-binding peptide in insulin-secreting cells and cerebral cortex. J Biol Chem 269:17768–17771Google Scholar
  31. 31.
    Spitzer NC (1979) Ion channels in development. Annu Rev Neurosci 2:363–397Google Scholar
  32. 32.
    Spruce AE, Standen NB, Stanfield PR (1987) Studies of the unitary properties of adenosine 5′-triphosphate-regulated potassium channels of frog skeletal muscle. J Physiol (Lond) 382:213–236Google Scholar
  33. 33.
    Spuler A, Lehmann-Horn F, Grafe P (1989) Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres. Naunyn Schmiedebergs Arch Pharmacol 339:327–331Google Scholar
  34. 34.
    Takano M, Noma A (1993) The ATP-sensitive K+ channel. Prog Neurobiol 41:21–30Google Scholar
  35. 35.
    Trezise DJ, Drew GM, Roach AG, Watts IS, Weston AH (1993) Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia. Eur J Pharmacol 250:109–116Google Scholar
  36. 36.
    Vivaudou MB, Arnoult C, Villaz M (1991) Skeletal muscle ATP-sensitive K+ channels recorded from sarcolemmal blebs of split fibers: ATP inhibition is reduced by magnesium and ADP. J Membr Biol 122:165–175Google Scholar
  37. 37.
    Weik R, Neumcke B (1989) ATP-sensitive potassium channels in adult mouse skeletal muscle: characterization of the ATP binding site. J Membr Biol 110:217–226Google Scholar
  38. 38.
    Weik R, Neumcke B (1990) Effects of potassium channel openers on single potassium channels in mouse skeletal muscle. Naunyn Schmiedebergs Arch Pharmacol 342:258–263Google Scholar
  39. 39.
    Westerblad H, Lee JA, Lännergren J, Allen DG (1991) Cellular mechanisms of fatigue in skeletal muscle. Am J Physiol 261:C195-C209Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Michel Fosset
    • 1
  • Bruno Allard
    • 2
  • Michel Lazdunski
    • 1
  1. 1.Institut de Pharmacologie Moléculaire et CellulaireSophia AntipolisFrance
  2. 2.Laboratoire de Physiologie des Eléments ExcitablesUniversité Claude BernardVilleurbanne CedexFrance

Personalised recommendations